Crystal Peak Investment Inc. - 26 Aug 2025 SCHEDULE 13D/A Report for LakeShore Biopharma Co., Ltd Ordinary Shares, par value $0.0002 per share (LSB)

Filing Manager
Crystal Peak Investment Inc.
Reporting Manager
Crystal Peak Investment Inc.
Security
LakeShore Biopharma Co., Ltd Ordinary Shares, par value $0.0002 per share
Symbol
LSB
Shares outstanding
41,218,298 shares
Disclosed Ownership
21,021,332 shares
Ownership
51%
Form type
SCHEDULE 13D/A
Filing time
27 Aug 2025, 09:02:30 UTC
Date of event
26 Aug 2025
Previous filing
22 Jul 2025
Next filing
29 Oct 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Huaqin Xue 51% 21,021,332 21,021,332 0 /s/ Huaqin Xue Huaqin Xue
Crystal Peak Holdings Inc. 51% 21,021,332 21,021,332 0 /s/ Huaqin Xue Huaqin Xue/Director
Crystal Peak Investment Inc. 51% 21,021,332 21,021,332 0 /s/ Huaqin Xue Huaqin Xue/Director 0002078050
Dave Liguang Chenn 1.1% 462,760 462,760 0 /s/ Dave Liguang Chenn Dave Liguang Chenn
Oceanpine Investment Fund II LP 1% 410,560 410,560 0 /s/ Dave Liguang Chenn Dave Liguang Chenn/Director
Oceanpine Capital Inc. 0.1% 52,200 52,200 0 /s/ Yang Jiayu Yang Jiayu/Director